ArticleJournal of clinical medicine2026
Platelet-to-Albumin Ratio and Clinical Outcomes in IDH-Wildtype Grade 4 Diffuse Glioma.
Ozan Deniz Guven, Asim Armagan Aydin, Ahmet Unlu, Hayrani Kaya, Fatma Su Ovali, Abdullah Umit, Murat Kocer, Banu Ozturk, Mustafa Yildiz
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Ozan Deniz GuvenDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Asim Armagan AydinDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0001-8749-9825 Ahmet UnluDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0001-6654-3815 Hayrani KayaDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Fatma Su OvaliDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Abdullah UmitDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Murat KocerDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Banu OzturkDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0003-0290-8787 Mustafa YildizDepartment of Clinical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
glioblastomaIDH-wildtype grade 4 diffuse gliomaMGMT promoter methylationneuro-oncologyoverall survivalplatelet-to-albumin ratioprognostic biomarkerprogression-free survivalsystemic inflammationtumor–host interaction
Identifiers
PMID42513426
PMCPMC13412166
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390